Should active CMV retinitis in non-immunocompromised newborn babies be treated? [6]

British Journal of Ophthalmology

Volumn 86, Issue 2, 2002, Pages 248-249

  Barampouti, F ^a   Rajan, M ^a   Aclimandos, W ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

CASE REPORT; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DEVELOPMENTAL DISORDER; HUMAN; LETTER; MALE; MICROCEPHALY; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; RETINA EXUDATE; RETINA HEMORRHAGE; RETINITIS; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; IMMUNOCOMPETENCE; INFANT, NEWBORN; MALE;

EID: 0036158959     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.2.248     Document Type: Letter

References (12)

1. The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations. Second of two parts
2. Outcome of symptomatic congenital CMV infection: Results of long term longitudinal follow-up
3. Virological and clinical observations on cytomegalic inclusion disease
4. Cytomegalovirus
5. Congenital and perinatal CMV infections
6. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for CMV retinitis
7. Screening for CMV retinitis in children
8. Congenital and perinatal CMV infections
9. The national congenital CMV disease registry, Collaborating group. Surveillance for CMV disease: A report from the National Congenital CMV disease registry
10. Auditory and visual defects resulting from symptomatic and subclinical congenital CMV and Toxoplasma infections
11. Late onset reactivation of chorioretinitis in children with congenital CMV infection
12. CMV retinitis in immunosuppressed children